Ann Liu

Ann Liu is a highly experienced biotechnologist with a strong background in producing, developing, and validating antibodies and other biologics. She has expertise in bioanalytical and cell-based functional assays for drug candidates, as well as in optimizing mammalian expression systems for recombinant antibodies and proteins. Ann has successfully delivered multiple monoclonal antibody drug candidates for immune checkpoint inhibitors.

With a Ph.D. in Biochemistry and Molecular Biology from Boston University School of Medicine and a Postdoctoral Fellowship in Biochemistry, Molecular, and Cell Biology from Massachusetts Institute of Technology, Ann has a solid academic foundation. She has held key roles in renowned organizations such as Abpro, Cell Signaling Technology, Boston University School of Medicine, NeoGenesis, Inc., and MIT, where she specialized in molecular biology, protein expression, purification, and characterization.

Ann Liu is known for providing troubleshooting and technical support to customers in cell culture, ELISA, FACS, cell-based assays, and protein expression. She is a self-driven biotechnologist with expertise in molecular biology, biochemistry, and cell biology. Ann excels in training and motivating others, possesses excellent communication skills, and is a dedicated team player with a focus on strategic planning and project efficiency.

Throughout her career, Ann has characterized and validated over 50 antibody products, presented seminars and posters at conferences, and managed CRO projects in antibody drug discovery. Her extensive experience in early therapeutic monoclonal antibody development, protein expression, and purification underscores her proficiency in the biologics industry. Ann Liu is committed to delivering high-quality results and meeting the needs of customers with her hard work and dedication.